PAR-25-159 - Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 4
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening | NOT-OD-22-179 | ODP , NIA , NIAAA , NIAMS , NICHD , NIDA , NIDCD , NIDCR , NIMH , NIMHD , NINDS , NINR , ODS , ORWH , SGMRO | Jul 14, 2022 | May 8, 2025 | R21, R01, R61/R33, UG3/UH3, R34, U01 |
Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan | NOT-OD-22-178 | ODP , NCI , NIA , NIAAA , NIAMS , NICHD , NIDA , NIDCD , NIDCR , NIMH , NIMHD , NINDS , NINR , ODS , ORWH , SGMRO | Jul 14, 2022 | May 8, 2025 | R21, R01, UG3/UH3, R61/R33, R34, R03 |
Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan | NOT-OD-22-106 | ODP , NCI , NIA , NIAAA , NIAMS , NICHD , NIDA , NIDCD , NIDCR , NIMH , NIMHD , NINDS , NINR , ODS , ORWH , SGMRO | May 12, 2022 | May 8, 2025 | R03, R01, R34, R21, UG3/UH3, R61/R33, 333 |
Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening | NOT-OD-22-107 | ODP , NIA , NIAAA , NIAMS , NICHD , NIDA , NIDCD , NIDCR , NIMH , NIMHD , NINDS , NINR , ODS , ORWH , SGMRO | May 12, 2022 | May 8, 2025 | 333, R01, R34, R21, R61/R33, U01, UG3/UH3 |
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|